Protagonist Therapeutics, Inc. (PTGX)
98.80
-5.17
(-4.97%)
USD |
NASDAQ |
May 07, 16:00
98.80
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Research and Development Expense (Annual) : 159.29M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| AbbVie, Inc. | 8.249B |
| Insmed, Inc. | 771.09M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| PTC Therapeutics, Inc. | 455.25M |